Viatris (VTRS) Finished Goods (2019 - 2026)
Viatris' (VTRS) quarterly Finished Goods came in at $2.0 billion in Q1 2026, down 6.06% year-on-year from $2.2 billion in Q1 2025, and down 2.53% quarter-over-quarter from $2.1 billion in Q4 2025.
Viatris (VTRS) Finished Goods (2019 - 2026) Analysis & Trends
Viatris' Finished Goods history runs 8 years deep, the most recent figure standing at $2.0 billion for Q1 2026.
- On a quarterly basis, Finished Goods fell 6.06% year-over-year to $2.0 billion in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 6.06% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 5.26% from the prior year.
- Finished Goods eased to $2.0 billion in Q1 2026 per VTRS's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Finished Goods topped out at $2.3 billion in Q1 2023 and bottomed at $1.8 billion in Q3 2022.
- The 5-year median for Finished Goods is $2.1 billion (2023), against an average of $2.1 billion.
- Across the five-year window, Finished Goods decreased 22.53% in 2022 and increased 18.19% in 2024, its largest moves.
- Year by year, Finished Goods stood at $2.2 billion in 2022, then fell by 2.59% to $2.1 billion in 2023, then declined by 7.26% to $2.0 billion in 2024, then climbed by 5.26% to $2.1 billion in 2025, then declined by 2.53% to $2.0 billion in 2026.
- Per Business Quant, the three latest VTRS Finished Goods figures stand at $2.0 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.03 Bn |
| Dec 31, 2025 | 2.09 Bn |
| Sep 30, 2025 | 2.08 Bn |
| Jun 30, 2025 | 2.19 Bn |
| Mar 31, 2025 | 2.16 Bn |
| Dec 31, 2024 | 1.98 Bn |
| Sep 30, 2024 | 2.24 Bn |
| Jun 30, 2024 | 2.12 Bn |
| Mar 31, 2024 | 2.04 Bn |
| Dec 31, 2023 | 2.14 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 2.09 Bn |
| Mar 31, 2023 | 2.30 Bn |
| Dec 31, 2022 | 2.19 Bn |
| Sep 30, 2022 | 1.77 Bn |
| Jun 30, 2022 | 1.99 Bn |
| Mar 31, 2022 | 2.16 Bn |
| Dec 31, 2021 | 2.06 Bn |
| Sep 30, 2021 | 2.29 Bn |
| Jun 30, 2021 | 2.39 Bn |